Roles of StearoylCoA Desaturase-1 in the Regulation of Cancer Cell Growth, Survival and Tumorigenesis

Menendez, 2007, Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis, Nat. Rev. Cancer, 7, 763, 10.1038/nrc2222

Kuhajda, 2006, Fatty acid synthase and cancer: New application of an old pathway, Cancer Res., 66, 5977, 10.1158/0008-5472.CAN-05-4673

Baron, 2004, Fatty acid synthase: A metabolic oncogene in prostate cancer?, J. Cell. Biochem., 91, 47, 10.1002/jcb.10708

Swinnen, 2006, Increased lipogenesis in cancer cells: New players, novel targets, Curr. Opin. Clin. Nutr. Metab. Care, 9, 358, 10.1097/01.mco.0000232894.28674.30

Enoch, 1976, Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid, J. Biol. Chem., 251, 5095, 10.1016/S0021-9258(17)33223-4

Wang, 2005, Characterization of HSCD5, a novel human stearoyl-CoA desaturase unique to primates, Biochem. Biophys. Res. Commun., 332, 735, 10.1016/j.bbrc.2005.05.013

Zhang, 1999, Human stearoyl-CoA desaturase: Alternative transcripts generated from a single gene by usage of tandem polyadenylation sites, Biochem. J., 340, 255, 10.1042/bj3400255

Ntambi, 2004, Regulation of stearoyl-CoA desaturases and role in metabolism, Prog. Lipid Res., 43, 91, 10.1016/S0163-7827(03)00039-0

Beiraghi, 2003, Identification and characterization of a novel gene disrupted by a pericentric inversion inv(4)(p13.1q21.1) in a family with cleft lip, Gene, 309, 11, 10.1016/S0378-1119(03)00461-X

Lengi, 2008, Comparison of pig, sheep and chicken SCD5 homologs: Evidence for an early gene duplication event, Comp. Biochem. Physiol. B Biochem. Mol. Biol., 150, 440, 10.1016/j.cbpb.2008.05.001

Pettitt, 2001, Phospholipase D1b and D2a generatestructurallyidenticalphosphatidic acid species in mammaliancells, Biochem. J., 360, 707, 10.1042/bj3600707

Deacon, 2002, Generation of diacylglycerol molecular species through the cell cycle: A role for 1-stearoyl, 2-arachidonyl glycerolintheactivationofnuclearproteinkinaseC-betaIIatG2/M, J.CellSci., 115, 983

Ivanova, 2004, ; Brown; H.A. LIPID arrays: New tools in the understanding of membrane dynamics and lipid signaling, Mol. Interv., 4, 86, 10.1124/mi.4.2.6

Igal, 2010, Stearoyl-CoA desaturase-1: A novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer, Carcinogenesis, 31, 1509, 10.1093/carcin/bgq131

Morton, 1976, Alteration of mitochondrial function and lipid composition in Morris 7777 hepatoma, Cancer Res., 36, 3246

Scaglia, 2005, High stearoyl-CoA desaturase protein and activity levels in simian virus 40 transformed-human lung fibroblasts, Biochim. Biophys. Acta., 1687, 141, 10.1016/j.bbalip.2004.11.015

Scaglia, 2009, Inhibition of Stearoyl-CoA Desaturase 1 inactivates acetyl-CoA carboxylase and impairs proliferation in human cancer cells. Role of AMPK, PLoS ONE, 4, e6812, 10.1371/journal.pone.0006812

Fritz, 2010, Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice, Mol. Cancer Ther., 9, 1740, 10.1158/1535-7163.MCT-09-1064

DeBerardinis, 2008, Brick by brick: Metabolism and tumor cell growth, Curr. Opin. Genet. Dev., 18, 54, 10.1016/j.gde.2008.02.003

DeBerardinis, 2008, The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation, Cell Metab., 7, 11, 10.1016/j.cmet.2007.10.002

Scaglia, 2005, Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells, J. Biol. Chem., 280, 25339, 10.1074/jbc.M501159200

Scaglia, 2008, Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis, Int. J. Oncol., 33, 839

Hess, 2010, Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells, PLoS One, 5, e11394, 10.1371/journal.pone.0011394

Hulver, 2005, Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans, Cell Metab., 2, 251, 10.1016/j.cmet.2005.09.002

Coleman, 2004, Enzymes of triacylglycerol synthesis and their regulation, Prog. Lipid Res., 43, 134, 10.1016/S0163-7827(03)00051-1

Li, 2009, Acyl-CoA synthesis, lipid metabolism and lipotoxicity, Biochim. Biophy. Acta., 1801, 246, 10.1016/j.bbalip.2009.09.024

Goodridge, 1972, Regulation of the activity of acetyl coenzyme A carboxylase by palmitoyl coenzyme A and citrate, J. Biol. Chem., 247, 6946, 10.1016/S0021-9258(19)44677-2

Ashcraft, 1980, Polymer-protomer transition of acetyl-CoA carboxylase occurs in vivo and varies with nutritional conditions, J. Biol. Chem., 255, 10033, 10.1016/S0021-9258(19)70420-7

Clarke, 1985, Fatty acid-mediated disaggregation of acetyl-CoA carboxylase in isolated liver cells, Fed. Proc., 44, 2458

Jackowski, 1996, Cell cycle regulation of membrane phospholipid metabolism, J. Biol. Chem., 1271, 20219, 10.1074/jbc.271.34.20219

Sugimoto, 2008, Transcriptional regulation of phosphatidylcholine biosynthesis, Prog. Lipid Res., 47, 204, 10.1016/j.plipres.2008.01.002

Siperstein, 1984, Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth, J. Lipid Res., 25, 1462, 10.1016/S0022-2275(20)34419-9

Demoulin, 2004, Platelet-derived growth factor stimulates membrane lipid synthesis through activation of phosphatidylinositol 3-kinase and sterol regulatory element-binding proteins, J. Biol. Chem., 279, 35392, 10.1074/jbc.M405924200

Chang, 2005, KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells, J Lipid Res., 46, 2624, 10.1194/jlr.M500154-JLR200

Swinnen, 2000, Selective activation of the fatty acid synthesis pathway in human prostate cancer, Int. J. Cancer, 88, 176, 10.1002/1097-0215(20001015)88:2<176::AID-IJC5>3.0.CO;2-3

Chajes, 2006, Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival, Cancer Res., 66, 5287, 10.1158/0008-5472.CAN-05-1489

Malumbres, 2009, Cell cycle, CDKs and cancer: a changing paradigm, Nat. Rev. Cancer, 9, 153, 10.1038/nrc2602

Lee, 1994, Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships, Proc. Natl. Acad. Sci. USA, 91, 10878, 10.1073/pnas.91.23.10878

Vork, 1997, Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes, J. Lipid Res., 38, 1384, 10.1016/S0022-2275(20)37421-6

Listenberger, 2003, Triglyceride accumulation protects against fatty acid-induced lipotoxicity, Proc. Natl. Acad. Sci. USA, 100, 3077, 10.1073/pnas.0630588100

Maedler, 2001, Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function, Diabetes, 50, 69, 10.2337/diabetes.50.1.69

Kharroubi, 2004, Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: Role of nuclear factor-kappaB and endoplasmic reticulum stress, Endocrinology, 145, 5087, 10.1210/en.2004-0478

Cnop, 2001, Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation, Diabetes, 50, 1771, 10.2337/diabetes.50.8.1771

Hardy, 2003, Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin, J. Biol. Chem., 278, 31861, 10.1074/jbc.M300190200

Wang, 2006, Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis, Endocrinology, 147, 943, 10.1210/en.2005-0570

Giacca, 2011, Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies, Am. J. Physiol. Endocrinol. Metab., 300, E255, 10.1152/ajpendo.00416.2010

Schaffer, 2003, Lipotoxicity: when tissues overeat, Curr. Opin. Lipidol., 14, 281, 10.1097/00041433-200306000-00008

Ariyama, 2010, Decrease in membrane phospholipid unsaturation induces unfolded protein response, J. Biol. Chem., 285, 22027, 10.1074/jbc.M110.126870

Pierre, 2010, Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells, PLoS One, 5, e14363, 10.1371/journal.pone.0014363

Borradaile, 2006, A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death, Mol. Biol. Cell, 17, 770, 10.1091/mbc.e05-08-0742

Erbay, 2009, Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis, Nat. Med., 15, 1383, 10.1038/nm.2067

Ostrander, 2001, Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis, J. Biol. Chem., 276, 38061, 10.1074/jbc.M107067200

Pinnamaneni, 2006, Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro, Diabetologia, 49, 3027, 10.1007/s00125-006-0427-9

Listenberger, 2001, Palmitate-induced apoptosis can occur through a ceramide-independent pathway, J. Biol. Chem., 276, 14890, 10.1074/jbc.M010286200

Porstmann, 2005, PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP, Oncogene, 24, 6465, 10.1038/sj.onc.1208802

Goldstein, 2006, Protein sensors for membrane sterols, Cell, 124, 35, 10.1016/j.cell.2005.12.022

Doble, 2003, GSK-3: Tricks of the trade for a multi-tasking kinase, J. Cell Sci., 116, 1175, 10.1242/jcs.00384

Arteaga, 2002, Epidermal growth factor receptor dependence in human tumors: More than just expression?, Oncologist, 4, 31, 10.1634/theoncologist.7-suppl_4-31

Vacaresse, 1999, Activation of epithelial growth factor receptor pathway by unsaturated fatty acids, Circ. Res., 85, 892, 10.1161/01.RES.85.10.892

Ge, 2001, Effect of membrane fluidity on tyrosine kinase activity of reconstituted epidermal growth factor receptor, Biochem. Biophys. Res. Commun., 282, 511, 10.1006/bbrc.2001.4600

Sun, 2003, Stearoyl-CoA desaturase inhibits ATP-binding cassette transporter A1-mediated cholesterol efflux and modulates membrane domain structure, J. Biol. Chem., 278, 5813, 10.1074/jbc.M208687200

Pike, 2009, The challenge of lipid rafts, J. Lipid Res., 50, S323, 10.1194/jlr.R800040-JLR200

Pike, 2005, Epidermal growth factor receptors are localized to lipid rafts that contain a balance of inner and outer leaflet lipids: A shotgun lipidomics study, J. Biol. Chem., 280, 26796, 10.1074/jbc.M503805200

Pike, 2002, Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking, Biochemistry, 41, 10315, 10.1021/bi025943i

Li, 1994, Partial characterization of a cDNA for human stearoyl-CoA desaturase and changes in its mRNA expression in some normal and malignant tissues, Int. J. Cancer, 57, 348, 10.1002/ijc.2910570310

Yahagi, 2005, Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma, Eur. J. Cancer, 41, 1316, 10.1016/j.ejca.2004.12.037

Horie, 2004, Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas, J. Clin. Invest., 113, 1774, 10.1172/JCI20513

Falvella, 2002, Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats, Carcinogenesis, 23, 1933, 10.1093/carcin/23.11.1933

Lu, 1997, Gene expression changes associated with chemically induced rat mammary carcinogenesis,, Mol. Carcinog., 20, 204, 10.1002/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M

Sharad, 2011, Prostate cancer gene expression signature of patients with high body mass index, Prostate Cancer Prostatic Dis., 14, 22, 10.1038/pcan.2010.44

Moore, 2005, Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma, Int. J. Cancer, 114, 563, 10.1002/ijc.20773

Winkvist, 1999, Fatty-acid composition in serum phospholipids and risk of breast cancer: An incident case-control study in Sweden, Int. J. Cancer, 83, 585, 10.1002/(SICI)1097-0215(19991126)83:5<585::AID-IJC2>3.0.CO;2-Z

Petrek, 1997, Fatty acid composition of adipose tissue, an indication of dietary fatty acids, and breast cancer prognosis, J. Clin. Oncol., 15, 1377, 10.1200/JCO.1997.15.4.1377

Pala, 2001, Erythrocyte membrane fatty acids and subsequent breast cancer: A prospective Italian study, J. Natl. Cancer Inst., 93, 1088, 10.1093/jnci/93.14.1088

Bougnoux, 1992, Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma, Breast Cancer Res. Treat., 20, 185, 10.1007/BF01834624

Zhu, 1995, Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease, Nutr. Cancer, 24, 151, 10.1080/01635589509514403

Simonsen, 1998, Tissue stores of individual monounsaturated fatty acids and breast cancer: the EURAMIC study. European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer, Am. J. Clin. Nutr., 68, 134, 10.1093/ajcn/68.1.134

Zureik, 1995, Fatty acid proportions in cholesterol esters and risk of premature death from cancer in middle aged French men, BMJ, 311, 1251, 10.1136/bmj.311.7015.1251

Joulin, 2010, The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk, Curr. Opin. Lipidol., 22, 6

Liu, 2007, Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors, J. Med. Chem., 50, 3086, 10.1021/jm070219p

Koltun, 2009, Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors, Bioorg. Med. Chem. Lett., 19, 2048, 10.1016/j.bmcl.2009.02.019

Koltun, 2009, Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors, Bioorg. Med. Chem. Lett., 19, 3050, 10.1016/j.bmcl.2009.04.004

Black, 2009, Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438), Bioorg. Med. Chem. Lett., 20, 499

Uto, 2009, Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-y]benzamide, Bioorg. Med. Chem. Lett., 19, 4151, 10.1016/j.bmcl.2009.05.119

Uto, 2009, Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-y]benzamide and its biological evaluation, Bioorg. Med. Chem. Lett., 19, 4159, 10.1016/j.bmcl.2009.05.123